Novavax COVID-19 vaccine shows 90.4% efficacy in late stage trial

14 Sept 00:18 Key points summarised by AI

Novavax's COVID-19 vaccine achieved over 90% efficacy in a late-stage U.S. and Mexico trial with nearly 30,000 volunteers, proving effective against various virus variants.
The protein-based vaccine demonstrated more than 93% effectiveness against predominant variants of concern, setting Novavax on track to file for emergency authorization in the third quarter of 2021.

Flooding persists in Bangkok and 22 provinces

Today 16:00 Key points summarised by AI

Persistent flooding continues across Bangkok and 22 Thai provinces, though water levels are gradually receding in many affected areas.
Over 604,000 families, impacting approximately 1.83 million people, are still grappling with the widespread flood conditions.
The national flood death toll has reached 80 since mid-September, with fatalities reported across various provinces.
Major regions like Pathum Thani, Ayutthaya, and Bangkok report significant numbers of affected households, with hundreds of thousands still in trouble.